As the chairs of the 2013 guideline panels on risk assessment and cholesterol treatment,1,2 we would like to clarify some statements made in 3 Viewpoint articles3- 5 and correct some misinterpretations or incorrect assumptions.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados